Previously, we identified a critical protein, NEK2, one of the never in mitosis associate (NIMA) kinase family – which has several putative roles in cell division, most notably in spindle formation and chromosome segregation6 – to be highly associated with poor prognosis and inferior survival in several different cancers, including head and neck squamous cell carcinoma, bladder carcinoma, glioblastoma, T‐cell acute lymphoblastic leukemia, colon carcinoma, hepatocellular carcinoma, melanoma, and ovarian adenocarcinoma, by the gene expression profiling (GEP) analysis. Here, NEK2 is linked to cancer.